Reasons why Recursion Pharmaceuticals Inc’s (NASDAQ:RXRX) fundamentals are futile
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.11, down -0.97% from the previous session. RXRX stock price is now -12.41% away from the 50-day moving average and -32.26% away from the 200-day moving average. The market capitalization of the company currently stands at $1.76B. With the price target of $8, […]